A new children’s book celebrates 29 New Zealanders who invented medical tools, led key health initiatives or revolutionised health care in some way. For a start, it tells us that a Timaru inventor created the first-ever disposable syringe!
Essilor’s latest innovation in the myopia-control space, spectacle lens Stellest 2.0, is now available in New Zealand.
Having served eyecare professionals in New Zealand and Australia for 20 years through distribution partners, Optopol is now stepping up its commitment to the region with the establishment of Optopol ANZ.
A University of Auckland-led qualitative study has added new detail to why eye donation remains low in Aotearoa New Zealand. These findings go beyond the system and infrastructure issues the research team already identified in NZ Optics October 2025.
Researchers in China found large-scale AI analysis of routine blood tests could help identify patients at higher risk of seven blinding eye diseases and prioritise them for confirmatory ophthalmic assessment.
Doctor and international rugby referee Ben O’Keeffe has added ‘Fred Hollows Foundation NZ ambassador’ as another string to his bow.
After more than a decade in its previous premises, Nelson Eye Surgeons has opened the doors to its new, purpose-designed clinic shaped by patient feedback and clinical need.For Nelson Eye Surgeons’ Drs Rob Jones and Antony Suter, the decision to move followed careful reflection on what their patient
Two years after the Optometry Council of Australia and New Zealand (OCANZ) launched the Māori Health Curriculum Framework, newly published research in Clinical and Experimental Optometry shows how the profession is beginning to translate it into teaching and assessment.
Apellis, the manufacturer of Syfovre for the treatment of geographic atrophy secondary to dry AMD, has partnered with a local supplier to make the treatment easier to access in New Zealand, despite a lack of Medsafe approval.
A literature review found that adopting the Mediterranean diet (or similar) appears beneficial for patients with age-related macular degeneration (AMD) at all disease stages.
One of EssilorLuxottica’s largest New Zealand graduate cohorts recently met in Sydney for the company’s annual Graduate Eyelaunch Event, said Essilor’s country eyecare manager New Zealand, Oliver Munro.
Scientists at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and collaborators have identified genetic pathways and compounds capable of protecting cone photoreceptors from the dege